Medocity recognized by Gartner in 5 separate Hype Cycle 2021 Healthcare Industry Reports
Parsippany, NJ – October 1, 2021
Medocity, a leader in digital care platform technology, has been recognized in five 2021 Gartner® Hype Cycle™ reports across five different technology categories. Gartner Hype Cycles provide a graphic representation of the maturity and adoption of technologies and applications, and how they are relevant to solving real business problems and exploiting new opportunities. Medocity’s platform was the only digital health platform endorsed across five major consumer, healthcare, and R&D industry reports including Digital Care Delivery (Virtual Care), Life Science R&D, Life Science Commercial Operations, U.S. Healthcare Payers, and Consumer Engagement with Healthcare and Wellness.
“Our inclusion in these Gartner Hype Cycle reports further validates Medocity’s focus on the need to reinvent patient experiences through smarter connections and real-time intelligence across the care continuum,” said Raj Agarwal, CEO and President at Medocity.
As Gartner indicates, our “technology captures the entire breadth of encounters between patients and the healthcare system by breaking down traditional healthcare data silos, while preserving the confidentiality of individual patients,” which ultimately “… enables life science organizations (LSOs) to refine their processes that target provider engagement and education initiatives, optimize sales and marketing resources, and identify patient cohorts that may benefit from their therapeutics.”
In fact, enabled by the most comprehensive, flexible cloud-based platform in the industry, Medocity’s solutions allow for the continuous capture of patient-centered data, while increasing retention and compliance, accelerating study timelines, improving outcomes, and lowering healthcare costs. The Gartner report also states that “real-world data (RWD) curation and analytics platforms [like Medocity], and the data and advanced analytics services they offer, are becoming critical components of the digital architecture of LSOs. These platforms enable LSOs to generate actionable insights that inform prelaunch and post-launch commercial activities, including competitive benchmarking, market sizing and surveillance, segmentation and profiling, sales performance management, and value-based contracting.”
In addition, Gartner analyst Jeff Smith explains that “digital trials are expected to have a significant business impact on clinical trials by automating the complicated data logistics needed to conduct trials. We anticipate digital trials to move faster, with greater ease finding and attracting subjects, and optimize existing data cleaning processes. Digital trials will put harder to measure disease conditions within reach and make plain to researchers more subtle indicators of health with digital wearables, dramatically impacting well-being.”
“We are delighted that Gartner has recognized Medocity for its enterprise Digital Care Platform in their recent published reports,” said Loreen M. Brown, LMSW, Global Head of Patient Support Solutions at Medocity. “Inclusion in five Gartner Hype Cycles across five different technology categories further underscores need for Medocity’s comprehensive, composable, patient-centric platform.”
References:
1 Gartner, Hype Cycle for U.S Payers, 2021, by Brian Cole, Jeff Cribbs, and Mandi Bishop, 13 July 2021
2 Gartner, Hype Cycle for Life Science Research and Development, 2021, Jeff Smith, Michael Shanler, 19 July, 2021
3 Gartner, Hype Cycle for Life Science Commercial Operations, 2021, Animesh Gandhi, 14 July 2021
4 Gartner, Hype Cycle for Digital Care Delivery including Virtual Care, 2021, Sharon Hakkennes, Mike Jones, 13 July 2021
5 Gartner, Hype Cycle for Consumer Engagement With Healthcare and Wellness, 2021, Kate McCarthy, 6 August, 2021
ABOUT MEDOCITY:
Medocity is a leading digital health solutions provider that supports decentralized clinical research and RWE generation through its unique, patient-focused end-to-end digital health enterprise platform serving pharmaceutical companies across clinical development and market commercialization. We collaborate with clinical development teams, CROs, sites and academic institutions from study concept to close, conducting decentralized clinical trials, including HEOR and RWE studies. Medocity engages patients throughout their disease journey to improve health outcomes; and enables the capture of continuous patient-centered data for trial and real-world clinical insights. Accessible in real time on any device, our technology seamlessly integrates with EMR data, claims data, lab data, EDC, CTMS and IRT systems, plus hundreds of connected sensors, sources and systems. Medocity’s unique AI/ML algorithm can match patients to rare disease clinical studies and also encourages inclusion and diversity. Our platform increases retention and compliance, accelerates study timelines, improves outcomes, and lowers healthcare costs. Any device. Any disease. Anywhere. Any time.
GARTNER DISCLAIMER:
Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
For more information, please visit www.medocity.com.
Medocity Media Contact:
Terence Maytin
(973) 671-5155
tmaytin@medocity.com
For Non-media Inquiries:
inquiry@medocity.com
(973) 679-8240
# # #